Beam Therapeutics BEAM Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's operating lease right-of-use assets in other assets?
- Beam Therapeutics (BEAM) reported operating lease right-of-use assets in other assets of $98.15M in Q1 2026.
- How has Beam Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Beam Therapeutics's operating lease right-of-use assets in other assets decreased by 4.0% year-over-year, from $102.22M to $98.15M.
- What is the long-term trend for Beam Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Beam Therapeutics's operating lease right-of-use assets in other assets has grown at a 3.0% compound annual growth rate (CAGR), from $86.86M to $100.68M.